Mustang Bio, Inc. financial data

Symbol
MBIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
377 Plantation Street, Worcester, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 66 % -86.1%
Debt-to-equity -772 % -894%
Return On Equity 1.4K %
Return On Assets -209 % -122%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 106M shares +16.7%
Entity Public Float 38.7M USD -20.7%
Weighted Average Number of Shares Outstanding, Basic 23.1M shares +185%
Weighted Average Number of Shares Outstanding, Diluted 23.1M shares +185%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 7.27M USD -34.9%
Operating Income (Loss) -32.8M USD +52.1%
Nonoperating Income (Expense) 755K USD
Net Income (Loss) Attributable to Parent -32.1M USD +55.2%
Earnings Per Share, Basic -2.75 USD/shares +69.2%
Earnings Per Share, Diluted -2.75 USD/shares +69.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.27M USD -72.3%
Assets, Current 7.32M USD -67.6%
Property, Plant and Equipment, Net 472K USD -87.5%
Operating Lease, Right-of-Use Asset 103K USD -94%
Other Assets, Noncurrent 250K USD -1.19%
Assets 8.52M USD -70.7%
Accounts Payable, Current 8.93M USD +33.1%
Liabilities, Current 15.9M USD +23.8%
Operating Lease, Liability, Noncurrent 656K USD -70.7%
Liabilities 16.8M USD +9.6%
Retained Earnings (Accumulated Deficit) -394M USD -8.85%
Stockholders' Equity Attributable to Parent -8.33M USD -161%
Liabilities and Equity 8.52M USD -70.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.32M USD +70.1%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.32M shares -93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.64M USD -71.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 148M USD +15.3%
Deferred Tax Assets, Gross 148M USD +14.8%
Operating Lease, Liability 1.09M USD -59%
Depreciation 1.09M USD -60%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 2.91M USD -12.1%
Property, Plant and Equipment, Gross 7.69M USD 0%
Operating Lease, Liability, Current 429K USD +4.89%
Lessee, Operating Lease, Liability, to be Paid, Year Two 703K USD -9.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 774K USD +7.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.83M USD +175%
Lessee, Operating Lease, Liability, to be Paid, Year Three 269K USD -61.7%
Deferred Tax Assets, Operating Loss Carryforwards 84.7M USD +12.9%
Preferred Stock, Shares Issued 250K shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 274K USD +1.86%
Operating Lease, Payments 156K USD +18.2%
Preferred Stock, Shares Outstanding 250K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 582K USD -46.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%